Advancing veterinary vaccines and biological products through science, innovation, quality, and continuous development.
Pasouk Knowledge-Based Company began its activities in 1994 with the aim of producing veterinary vaccines and biological products. Through the efforts and research of its specialists, the company has developed and supplied important and strategic vaccines for the livestock and poultry industries, as well as antigens required for laboratory applications.
Pasouk applies clinical, laboratory, epidemiological, and scientific research to the development of vaccines and biological products for the diagnosis, prevention, and control of infectious diseases. These activities contribute to improving public health, strengthening biotechnology infrastructure, supporting self-sufficiency in strategic products, and reducing dependence on imported vaccines and biological products.
From our beginnings in 1994 to the expansion of our production capabilities, Pasouk has continued to develop its scientific, technological, and manufacturing capacity.
Pasouk began its activities with the aim of producing veterinary vaccines and biological products.
Through clinical, laboratory, epidemiological, and scientific research, Pasouk has expanded its capabilities in the development of vaccines and biological products.
Over the past 10 years, three new production halls have been opened, significantly increasing production capacity and product diversity.
Several innovative projects are approaching the implementation stage, supporting the continued expansion of Pasouk's product portfolio and technological capabilities.
Our development activities cover a broad range of veterinary vaccines and biological products for livestock and poultry.
Development of a six-valent clostridial toxoid vaccine as part of Pasouk's strategic product development activities.
Development of live poultry vaccines against Newcastle disease, infectious bronchitis, Gumboro disease, Marek's disease, chicken infectious anemia, and ILT.
Development of an inactivated trivalent poultry vaccine containing ND (G7), Angara, and EDS.
Pasouk products are manufactured under GMP principles using raw materials that meet the highest international standards, state-of-the-art equipment, and experienced personnel. Quality control is carried out in equipped quality-control laboratories. Products are subject to approval by the Iranian Veterinary Organization and are distributed throughout Iran.
Scientific quality control and modern manufacturing practices throughout the production process.
Pasouk's activities extend across research, infrastructure, collaboration, representation, and professional development.
Research and development of new biological products based on scientific and technical objectives.
Creating and developing facilities for breeding and maintaining laboratory animals for educational and research centers.
Developing strategic relationships with public and private institutions in Iran.
Planning domestic and international representation and export of vaccines, pharmaceuticals, laboratory, and health products within applicable laws.
Creating employment opportunities and supporting professional knowledge development for graduates in veterinary medicine, microbiology, and related fields.
Building a stronger future for veterinary health through knowledge, innovation, quality, and continuous development.